We are live on
!
Find out more
LBA
Letko, Brosseau & Associates Portfolio holdings
AUM
$6.2B
1-Year Est. Return
38.92%
This Fund
S&P 500
This Quarter
Est. Return
-10.01%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+305.85%
AUM
$9.82B
AUM Growth
-$1.1B
(-10%)
Cap. Flow
+$250M
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
31.06%
Holding
106
New
5
Increased
35
Reduced
41
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$82M |
| 2 |
Oracle
ORCL
|
+$78.6M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$69.9M |
| 4 |
Royal Bank of Canada
RY
|
+$49.4M |
| 5 |
Scotiabank
BNS
|
+$35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$143M |
| 2 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$38M |
| 3 |
Pfizer
PFE
|
+$20.8M |
| 4 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
+$9.28M |
| 5 |
Goodyear
GT
|
+$7.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.33% |
| 2 | Energy | 16.87% |
| 3 | Communication Services | 14.14% |
| 4 | Technology | 9.85% |
| 5 | Industrials | 8.88% |
Similar funds
NP
WIA
EIP
B
CA
ACM
AWA
DTC
Letko, Brosseau & Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Letko, Brosseau & Associates held 106 positions worth $9.82B, down 10% from $10.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Letko, Brosseau & Associates's Q3 2015 filing shows 5 new, 35 increased, 41 reduced and 4 closed positions. Its largest new stake was Merck: 1,542,999 shares worth $72.7M. The largest sale was Baxter International, an estimated $143M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Energy and Communication Services.
- Letko, Brosseau & Associates's largest Q3 2015 buy was Merck: 1,542,999 shares worth $72.7M.
- Letko, Brosseau & Associates added most to Royal Bank of Canada in Q3 2015, an estimated $49.4M increase.
- Letko, Brosseau & Associates's biggest Q3 2015 reduction was LifePoint Health, Inc., cutting an estimated $38M.
- Letko, Brosseau & Associates fully exited Baxter International in Q3 2015, selling an estimated $143M.
- Letko, Brosseau & Associates's ten largest holdings make up 31% of its $9.82B portfolio in Q3 2015.
- Letko, Brosseau & Associates opened 5 new positions and closed 4 in Q3 2015.
- Letko, Brosseau & Associates's portfolio value fell 10% quarter-over-quarter to $9.82B.
Based on Letko, Brosseau & Associates's 13F filing for Q3 2015, filed 12 Nov 2015.